Therapy to improve control and reduce symptoms in children with non-epileptic seizures
Official title: Retraining and Control Therapy (ReACT): Sense of Control and Catastrophic Symptom Expectations as Targets of a Cognitive Behavioral Treatment for Pediatric Psychogenic Non-epileptic Seizures (PNES)
Run by University of Alabama at Birmingham · NCT05096273 · Data updated 2026-11-12
This study is testing a new therapy called ReACT to see if it can help children aged 9-18 with non-epileptic seizures feel more in control and reduce their symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 11 Years to 18 Years |
| Sex | All |
| Enrollment | 68 (estimated) |
| Sponsor | University of Alabama at Birmingham Academic / other |
| Locations | 1 site (Birmingham, Alabama) |
| Status | Recruiting |
| Started | October 28, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | August 31, 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT05096273 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 9-18 with a confirmed diagnosis of psychogenic non-epileptic seizures.
✕Probably not a fit
Patients with comorbid epilepsy or those experiencing fewer than four PNES episodes per month may not benefit from this therapy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of Retraining and Control Therapy (ReACT) in treating pediatric patients aged 9-18 diagnosed with psychogenic non-epileptic seizures (PNES). Participants will undergo twelve therapy sessions aimed at enhancing their sense of control and reducing catastrophic symptom expectations. The study employs various assessments, including pain tolerance tests and cortisol measurements, to gauge the therapy's impact. Follow-up visits will occur at 6 and 12 months post-treatment to monitor long-term outcomes.
Why it matters
Potential benefit: If successful, this therapy could significantly improve the quality of life for children suffering from PNES by enhancing their sense of control and reducing anxiety related to their symptoms.
How similar studies have gone: While this approach is innovative, similar studies targeting psychological aspects of seizure disorders have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 9-18 years old. * Diagnosis of psychogenic non-epileptic seizures by a medical doctor using video-EEG. * Family member (parent if a minor) willing to participate and that the subject with PNES chooses. Exclusion Criteria: * Comorbid Epilepsy * Less than 4 PNES per month * Other paroxysmal nonepileptic events (e.g. episodes related to hypoxic-ischemic phenomena, sleep disorders or migraine-associated disorders) * Participation in other therapy * Severe intellectual disability * Severe mental illness (delusions/hallucinations) Exclusion for CPT: * Blood pressure \>130/80 mmHg for adolescents greater than or equal to 13 years old * Either systolic and/or diastolic blood pressure greater than or equal to 95% based on sex and age for children less than 13 years old
Where it's running
-
Sparks Center Office of Psychiatric Research
Birmingham, Alabama, United States Recruiting
Study contacts
- Study coordinator: Aaron Fobian, PhD
- Email: afobian@uabmc.edu
- Phone: 205-934-2241
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Retraining and Control Therapy for adults with non-epileptic seizures
This study is testing a new therapy called Retraining and Control Therapy to see if it can help adults with non-epileptic seizures feel more in control and reduce their worries about their symptoms.
-
Creating a treatment program for functional neurological disorder
This study is trying to create a new treatment plan for people with functional neurological disorder by bringing together different types of therapy to see if it helps both kids and adults feel better.
-
Therapy to improve control and reduce symptoms in children with non-epileptic seizures
This study is testing a new therapy called ReACT to see if it can help children aged 11-18 with non-epileptic seizures feel more in control and reduce their symptoms.
-
Feasibility of a new mind and body treatment for pediatric functional seizures
This study is testing if two different treatments for kids with functional seizures work well enough to be used in a larger trial.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.